20 AIDX
NASDAQ AIDX
$0.51 +0.01 (+1.26%)
At close: Aug 20, 2026 · 2:28 PM UTC

20 (AIDX) Cash from Operations Growth (1y) (2026)

20 (AIDX) Cash from Operations Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 199.46 Bn 193.86 Bn 7.27 Bn 21.54%
2 Stryker 127.41 Bn 123.93 Bn 4.50 Bn 13.50%
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn 1.78%
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn 14.62%
5 Edwards Lifesciences 51.95 Bn 47.69 Bn 1.35 Bn 124.64%
6 Dexcom 34.30 Bn 32.35 Bn 830.00 Mn -11.16%
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 78.72%
8 Koninklijke Philips 26.35 Bn 23.02 Bn 4.55 Bn -0.23%
9 Steris 23.04 Bn 22.55 Bn 684.20 Mn -12.60%
10 20 5.56 Mn 1.01 Mn 304,727.00 -13.36%

Historic Data

Download Data
DateValue
Mar 31, 2026 -163.97%